Showing results (21-30 of 103) with videos related to
Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 21, 2022
Medicaid Spending on Antiretrovirals From 2007 Through 2019Bryan S Walsh, Aaron S Kesselheim, Benjamin N RomeCurrent Cardiology Reports|April 25, 2014
Approval of high-risk medical devices in the US: implications for clinical cardiologyBenjamin N Rome, Daniel B Kramer, Aaron S KesselheimHealth Services Research|February 23, 2023
Market dynamics of authorized generics in Medicaid from 2014 to 2020Benjamin N Rome, Simon J Gunter, Aaron S KesselheimHealth Services Research|July 14, 2025
Share of Sales Subject to Medicare Inflation Rebates and Price Increases of Top-Selling DrugsAlexander C Egilman, Aaron S Kesselheim, Benjamin N RomeThe Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|May 31, 2024
Medicare Should Cover Weight Loss Drugs as Long as the Prices are AffordableCatherine S Hwang, Aaron S Kesselheim, Benjamin N RomeJAMA Internal Medicine|September 8, 2020
US Spending Associated With Transition From Daily to 3-Times-Weekly Glatiramer AcetateBenjamin N Rome, Frazer A Tessema, Aaron S KesselheimJAMA Network Open|January 15, 2026
Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare PatientsJacob S Riegler, Aaron S Kesselheim, Benjamin N RomeHealth Affairs (Project Hope)|May 3, 2021
Frequency Of Generic Drug Price Spikes And Impact On Medicaid SpendingAayan N Patel, Aaron S Kesselheim, Benjamin N RomeJAMA|April 18, 2023
Added Therapeutic Benefit of Top-Selling Brand-name Drugs in MedicareAlexander C Egilman, Benjamin N Rome, Aaron S KesselheimClinical Pharmacology and Therapeutics|July 13, 2020
Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012-2018Benjamin N Rome, ChangWon C Lee, Aaron S KesselheimPageof 11